Drug class
Polyfunctional alkylating antineoplastic agent; piperazine derivative
Mechanism of action
The precise mechanism is not fully elucidated. It is classified as an alkylating agent and is thought to alkylate DNA, disrupting DNA replication and synthesis and ultimately inducing cell death.
General use cases
- Historically used for cytoreductive treatment of polycythaemia vera and essential thrombocythaemia in selected countries; availability and use are jurisdiction-specific and it is not a routine first-line treatment.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
